71 related articles for article (PubMed ID: 28875726)
21. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer.
Dong M; Fan XJ; Chen ZH; Wang TT; Li X; Chen J; Lin Q; Wen JY; Ma XK; Wei L; Ruan DY; Lin ZX; Liu Q; Wu XY; Wan XB
Oncol Rep; 2014 Sep; 32(3):1101-7. PubMed ID: 25017254
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the prognostic value of CBXs in gastric cancer patients.
He M; Yue L; Wang H; Yu F; Yu M; Ni P; Zhang K; Chen S; Duan G; Zhang R
Sci Rep; 2021 Jun; 11(1):12375. PubMed ID: 34117289
[TBL] [Abstract][Full Text] [Related]
24. 3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death.
Tam EK; Nguyen TM; Lim CZ; Lee PL; Li Z; Jiang X; Santhanakrishnan S; Tan TW; Goh YL; Wong SY; Yang H; Ong EH; Hill J; Yu Q; Chai CL
ChemMedChem; 2015 Jan; 10(1):173-82. PubMed ID: 25319940
[TBL] [Abstract][Full Text] [Related]
25. Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.
Wang XF; Zhang XW; Hua RX; Du YQ; Huang MZ; Liu Y; Cheng YF; Guo WJ
Oncotarget; 2016 Sep; 7(39):63352-63361. PubMed ID: 27542229
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients.
Liang M; Shi B; Liu J; He L; Yi G; Zhou L; Yu G; Zhou X
Drug Des Devel Ther; 2015; 9():3607-16. PubMed ID: 26213461
[TBL] [Abstract][Full Text] [Related]
28. High Hepsin expression predicts poor prognosis in Gastric Cancer.
Zhang M; Zhao J; Tang W; Wang Y; Peng P; Li L; Song S; Wu H; Li C; Yang C; Wang X; Zhang C; Gu J
Sci Rep; 2016 Nov; 6():36902. PubMed ID: 27841306
[TBL] [Abstract][Full Text] [Related]
29. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
[TBL] [Abstract][Full Text] [Related]
30. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
31. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
[TBL] [Abstract][Full Text] [Related]
32. PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis.
Kwon CH; Park HJ; Choi YR; Kim A; Kim HW; Choi JH; Hwang CS; Lee SJ; Choi CI; Jeon TY; Kim DH; Kim GH; Park do Y
Oncotarget; 2016 Apr; 7(16):21454-68. PubMed ID: 26894977
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
34. Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.
Wu C; Zheng X; Li X; Fesler A; Hu W; Chen L; Xu B; Wang Q; Tong A; Burke S; Ju J; Jiang J
Oncotarget; 2016 Mar; 7(12):14522-36. PubMed ID: 26894855
[TBL] [Abstract][Full Text] [Related]
35. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
37. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
38. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S
Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045
[TBL] [Abstract][Full Text] [Related]
39. The specific alteration of histone methylation profiles by DZNep during early zebrafish development.
Ostrup O; Reiner AH; Aleström P; Collas P
Biochim Biophys Acta; 2014 Nov; 1839(11):1307-15. PubMed ID: 25260724
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of the Expression and Prognosis of chromobox Family Members in Breast Cancer.
Wang L; Zhao L; Zhang Y; Shao S; Ning Q; Zhao X; Luo M
Clin Breast Cancer; 2023 Jun; 23(4):e206-e218. PubMed ID: 36890004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
